Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2021 Aug 25;22(10):2016–2020.e2. doi: 10.1016/j.jamda.2021.08.015

COVID-19 Vaccine Uptake Among Residents and Staff Members of Assisted Living and Residential Care Communities—Pharmacy Partnership for Long-Term Care Program, December 2020–April 2021

Radhika Gharpure a,, Sarah H Yi a, Ruoran Li a, Kara M Jacobs Slifka a,b, Ashley Tippins a, Aaron Jaffe c, Angela Guo a, Alyssa G Kent a, Katryna A Gouin a, J Carrie Whitworth a,b, Nicholas Vlachos a, Anita Patel a, Matthew J Stuckey a,b, Ruth Link-Gelles a,b
PMCID: PMC8384582  PMID: 34508695

Abstract

Objectives

In December 2020, CDC launched the Pharmacy Partnership for Long-Term Care Program to facilitate COVID-19 vaccination of residents and staff in long-term care facilities (LTCFs), including assisted living (AL) and other residential care (RC) communities. We aimed to assess vaccine uptake in these communities and identify characteristics that might impact uptake.

Design

Cross-sectional study.

Setting and Participants

AL/RC communities in the Pharmacy Partnership for Long-Term Care Program that had ≥1 on-site vaccination clinic during December 18, 2020–April 21, 2021.

Methods

We estimated uptake using the cumulative number of doses of COVID-19 vaccine administered and normalizing by the number of AL/RC community beds. We estimated the percentage of residents vaccinated in 3 states using AL census counts. We linked community vaccine administration data with county-level social vulnerability index (SVI) measures to calculate median vaccine uptake by SVI tertile.

Results

In AL communities, a median of 67 residents [interquartile range (IQR): 48-90] and 32 staff members (IQR: 15-60) per 100 beds received a first dose of COVID-19 vaccine at the first on-site clinic; in RC, a median of 8 residents (IQR: 5-10) and 5 staff members (IQR: 2-12) per 10 beds received a first dose. Among 3 states with available AL resident census data, median resident first-dose uptake at the first clinic was 93% (IQR: 85-108) in Connecticut, 85% in Georgia (IQR: 70-102), and 78% (IQR: 56-91) in Tennessee. Among both residents and staff, cumulative first-dose vaccine uptake increased with increasing social vulnerability related to housing type and transportation.

Conclusions and Implications

COVID-19 vaccination of residents and staff in LTCFs is a public health priority. On-site clinics may help to increase vaccine uptake, particularly when transportation may be a barrier. Ensuring steady access to COVID-19 vaccine in LTCFs following the conclusion of the Pharmacy Partnership is critical to maintaining high vaccination coverage among residents and staff.

Keywords: COVID-19, vaccination, vaccination coverage, long-term care


Following the US Food and Drug Administration's Emergency Use Authorizations of the first vaccines for prevention of coronavirus disease 2019 (COVID-19), the Advisory Committee on Immunization Practices recommended that residents and staff members of long-term care facilities (LTCFs) be prioritized in the first phase of COVID-19 vaccine allocation.1 As congregate settings, LTCFs pose increased risk for transmission of SARS-CoV-2, the virus that causes COVID-19,2 and residents are also at increased risk for severe COVID-19 illness due to older age or underlying health conditions.3 LTCFs include skilled nursing facilities (SNFs) and other nursing homes, assisted living (AL) and other residential care (RC) communities, and residential facilities for persons with intellectual and developmental disabilities. AL/RC communities provide assistance with activities of daily living (eg, bathing and toileting) and may also provide some health care services (eg, management and administration of medications) in a residential setting; these communities represent approximately 44% of US LTCFs.4 Data from October 2020 indicated that 22% of AL/RC communities with available data reported at least 1 case of COVID-19 among residents or staff members, and that COVID-19–associated mortality among the resident population was significantly higher than that among the general population (21% vs 3%).5

To facilitate COVID-19 vaccination of residents and staff members in LTCFs, CDC launched the Pharmacy Partnership for Long-Term Care Program in December 2020.6 This program, a public-private partnership with 3 pharmacies (CVS, Managed Health Care Associates, and Walgreens), conducted on-site visits to enrolled LTCFs to provide end-to-end management of the COVID-19 vaccination process, including appropriate storage, handling, and transport of vaccines, vaccine administration, and fulfillment of reporting requirements. More than 62,000 LTCFs across 49 states enrolled in the program and received on-site vaccinations for residents and staff members. Early estimates from the first month of the program indicated that a median of 78% of residents and 38% of staff members in SNFs received at least a first dose of COVID-19 vaccine.7 Complementing these results, we aimed to assess vaccine uptake in AL/RC communities participating in the program and identify community and county characteristics that might impact uptake. Specifically, we assessed the association between uptake and county-level social vulnerability, which has been shown to impact COVID-19 vaccine uptake in LTCFs8 and broader population settings.9, 10, 11

Methods

Participating pharmacies reported LTCF-level aggregate COVID-19 vaccine administration data to CDC through a web-based data platform. This analysis included AL/RC communities that had at least 1 on-site vaccination clinic run by a participating pharmacy from December 18, 2020 (date of first on-site clinic), through April 21, 2021 (date of clinic completion for >99% enrolled communities; data as of April 28, 2021). Communities were classified as AL or RC based on self-identification during program signup. Pfizer-BioNTech COVID-19 vaccine and Moderna COVID-19 vaccine were administered through the program; both products required a 2-dose series for completion. Pharmacies generally conducted 3 on-site clinics at each community for administration of first and second vaccine doses; clinics were scheduled approximately 21-28 days apart depending on vaccine product. Smaller communities may have received only 2 clinics if all residents and staff members were vaccinated and a third clinic was not deemed necessary.

To estimate uptake, we calculated the cumulative number of first and second doses of vaccine administered to residents and staff members at each clinic and normalized by the reported total bed capacity per community (presented as number vaccinated per 100 reported beds for AL communities and per 10 reported beds for RC communities to account for differences in average community size; Supplementary Tables 1-2). Additionally, we estimated the percentage of residents who received a first dose of COVID-19 vaccine in AL communities in 3 states (Connecticut,12 Georgia,13 and Tennessee14) that reported resident census counts (number of occupied beds) in publicly available COVID-19 reports obtained via systematic website searches5 during February 2-4, 2021. AL census counts were not available for additional states; RC census counts were available only for a small number of communities and were not included because of insufficient sample size. We linked community-level vaccination data from these states to AL census data using standardized values of community name and address. We calculated the estimated first-dose uptake per 100 residents by dividing the number of first doses of COVID-19 vaccine administered by the reported census count. Estimated first-dose uptake exceeded 100% if reported doses administered were greater than resident census counts.

We linked AL/RC communities with county-level social vulnerability index (SVI) measures.15 SVI is based on county rankings of 15 census measures associated with social determinants of health and is summarized in 4 themes: (1) socioeconomic status, (2) household composition and disability status, (3) racial or ethnic minority status and language, and (4) housing type and transportation. A higher SVI score indicates higher social vulnerability. For communities without a reported Federal Information Processing Standards (FIPS) code (used for identification of US counties), the address zip code was mapped to the corresponding county FIPS code in the US Department of Housing and Urban Development–US Postal Service zip Code Crosswalk.16 When multiple counties mapped to a single zip code, we chose the county with the highest proportion of residential and business addresses. Counties were classified into tertiles for each of the 4 SVI themes. We calculated the median vaccine first-dose uptake among residents and staff members of AL/RC communities by SVI tertile.

All analyses were performed using SAS statistical software (version 9.4; SAS Institute, Cary, NC) and R (version 4.0.2, R Core Team, Vienna, Austria). This activity was reviewed by CDC and was conducted consistent with applicable federal law and CDC policy.

Results

As of April 21, 2021, 18,980 AL communities and 16,874 RC communities conducted COVID-19 vaccination clinics through the Pharmacy Partnership for Long Term Care Program. In total, 765,792 residents and 513,293 staff members in AL communities and 222,987 residents and 213,146 staff in RC communities received at least 1 COVID-19 vaccine dose. The median bed size was 35 [interquartile range (IQR): 10-77] among participating AL communities and 6 (IQR: 4-6) among RC communities.

In AL communities, a median of 67 residents (IQR: 48-90) and 32 staff members (IQR: 15-60) per 100 beds received a first dose of vaccine at the first on-site clinic; in RC communities, a median of 8 residents (IQR: 5-10) and 5 staff members (IQR: 2-12) per 10 beds received a first dose (Table 1 ). Cumulatively as of April 21, 2021, a median of 75 residents (IQR: 54-100) and 47 staff members (IQR: 24-85) per 100 beds in AL communities received a first dose of vaccine, and 66 residents (IQR: 45-88) and 37 staff members (IQR: 17-70) per 100 beds received a second dose. In RC communities, a median of 9 residents (IQR: 7-13) and 8 staff members (IQR: 3-18) per 10 beds received a first dose of vaccine, and 8 residents (IQR: 5-10) and 7 staff members (IQR: 2-14) per 10 beds received a second dose.

Table 1.

COVID-19 Vaccine Uptake in Assisted Living and Residential Care Communities—Pharmacy Partnership for Long-Term Care Program, December 2020–April 2021

Assisted Living: Cumulative Vaccine Uptake, Median (IQR) per 100 Beds
(n = 18,980)
Residential Care: Cumulative Vaccine Uptake, Median (IQR) per 10 Beds
(n = 16,874)
Residents
 First dose
 Clinic 1 67 (48-90) 8 (5-10)
 Clinic 2 75 (54-100) 9 (7-12)
 Clinic 3 75 (54-100) 9 (7-13)
 Second dose
 Clinic 1 0 (0-0) 0 (0-0)
 Clinic 2 60 (40-82) 7 (4-10)
 Clinic 3 66 (45-88) 8 (5-10)
Staff members
 First dose
 Clinic 1 32 (15-60) 5 (2-12)
 Clinic 2 44 (23-81) 8 (3-17)
 Clinic 3 47 (24-85) 8 (3-18)
 Second dose
 Clinic 1 0 (0-0) 0 (0-0)
 Clinic 2 28 (12-56) 5 (1-10)
 Clinic 3 37 (17-70) 7 (2-14)

Communities self-identified as assisted living (AL) or other residential care (RC) for this analysis. Classification and characteristics of AL and RC communities can differ by state; however, RC communities are generally smaller than AL communities. Additionally, AL communities might offer various levels of on-site nursing or medical care whereas RC communities might not; the care offered is less extensive than what is offered in a skilled nursing facility or nursing home.

Uptake is presented as number vaccinated per 100 reported beds for AL communities and per 10 reported beds for RC communities to account for differences in community size; median bed size was 35 (interquartile range [IQR]: 10-77) in AL and 6 (IQR: 4-6) in RC.

Smaller communities may not have conducted third clinics if all residents and staff members were vaccinated in the first 2 clinics. Third clinics were conducted in 15,025 (79%) AL communities and 9881 (59%) RC communities as of April 21, 2021.

Resident census data were available for 89 of 118 (75%) participating AL communities in Connecticut, 192 of 330 (58%) in Georgia, and 232 of 289 (80%) in Tennessee (Table 2 ). The median percentage of beds occupied was 68% (IQR: 55-81) in Connecticut, 58% (IQR: 48-69) in Georgia, and 70% (IQR: 58-84) in Tennessee. This resulted in an estimated median resident first-dose uptake of 93% (IQR: 85-108) in Connecticut, 85% in Georgia (IQR: 70-102), and 78% (IQR: 56-91) in Tennessee at the first on-site clinic. Cumulatively as of April 21, 2021, first-dose uptake increased to 106% (IQR: 97-131) in Connecticut, 98% in Georgia (IQR: 84-120), and 88% (IQR: 66-100) in Tennessee.

Table 2.

First-Dose COVID-19 Vaccine Uptake Among Residents, by Bed Capacity and Resident Occupancy, in Assisted Living Communities—Pharmacy Partnership for Long-Term Care Program, December 2020-April 2021

Variable CT
GA
TN
Unlinked,
Median (IQR)
(n = 29)
Linked,
Median (IQR)
(n = 89)
Unlinked,
Median (IQR)
(n = 138)
Linked,
Median (IQR)
(n = 192)
Unlinked,
Median (IQR)
(n = 57)
Linked,
Median (IQR)
(n = 232)
Occupancy-to-capacity ratio 68 (55-81) 58 (48-69) 70 (58-84)
Clinic 1
 Uptake per 100 beds 55 (41-63) 68 (55-83) 51 (31-71) 49 (36-63) 54 (42-67) 53 (40-71)
 Uptake per 100 residents (%) 93 (85-108) 85 (70-102) 78 (56-91)
Clinic 2
 Uptake§ per 100 beds 65 (48-78) 75 (60-92) 60 (37-79) 57 (43-75) 57 (44-72) 59 (45-75)
 Uptake§ per 100 residents (%) 103 (95-119) 97 (82-117) 88 (64-100)
Clinic 3
 Uptake§ per 100 beds 65 (52-80) 77 (61-96) 61 (38-83) 59 (44-76) 57 (44-73) 59 (46-76)
 Uptake§ per 100 residents (%) 106 (97-131) 98 (84-120) 88 (66-100)

“Unlinked” indicates communities not matched to publicly available resident census data; “linked” indicates communities matched to resident census data. Uptake per 100 residents was calculated only for linked communities. Census data were available for AL communities in 3 states; RC census data were available only for a small number of facilities and are not presented.

Occupancy-to-capacity ratio was calculated as resident census (dated January 27–February 2, 2021) divided by total number of reported beds.

First-dose uptake per 100 beds was calculated as number of first doses of COVID-19 vaccine administered normalized per 100 reported beds (total bed capacity). First-dose uptake per 100 residents was calculated as number of first doses of COVID-19 vaccine administered normalized per 100 residents in census counts (occupied beds).

§

Uptake for clinics 2 and 3 is cumulative vaccine uptake inclusive of previous clinics.

Among the 35,854 participating AL/RC communities, 34,934 (97%) were linked to county-level SVI data. For both residents and staff members, cumulative first-dose vaccine uptake decreased with increasing social vulnerability related to socioeconomic status (SVI theme 1) and household composition and disability status (SVI theme 2) (Figure 1 ). However, uptake increased with increasing social vulnerability related to racial orethnic minority status and language (SVI theme 3) and housing type and transportation (SVI theme 4).

Fig. 1.

Fig. 1

First-dose COVID-19 vaccine uptake,∗ by social vulnerability index (SVI) theme and tertile, among residents and staff members of assisted living (A and B) and other residential care (C and D) communities—Pharmacy Partnership for Long-Term Care Program, December 2020–April 2021. ∗Includes cumulative first-dose vaccine uptake as of April 21, 2021. SVI ranks counties according to 15 social factors (indicators): (1) percentage of persons with incomes below poverty threshold, (2) percentage of civilian population (aged ≥16 years) that is unemployed, (3) per capita income, (4) percentage of persons aged ≥25 years with no high school diploma, (5) percentage of persons aged ≥65 years, (6) percentage of persons aged ≤17 years, (7) percentage of civilian noninstitutionalized population with a disability, (8) percentage of single-parent households with children aged <18 years, (9) percentage of persons who are racial/ethnic minorities (all persons except non-Hispanic White), (10) percentage of persons aged ≥5 years who speak English “less than well,” (11) percentage of housing structures with ≥10 units (multiunit housing), (12) percentage of housing structures that are mobile homes, (13) percentage households with more persons than rooms (crowding), (14) percentage of households with no vehicle available, and (15) percentage of persons in group quarters. Estimates are created using 2014-2018 (5-year) data from the American Community Survey. The 15 indicators are categorized into 4 themes: (1) socioeconomic status (indicators 1-4), (2) household composition and disability (indicators 5-8), (3) racial/ethnic minority status and language English (indicators 9 and 10), and (4) housing type and transportation (indicators 11-15). Additional details are available at https://www.atsdr.cdc.gov/placeandhealth/svi/documentation/SVI_documentation_2018.html. Higher tertile indicates increased social vulnerability.

Discussion

Early data have indicated that COVID-19 vaccination is effective in reducing the risk for SARS-CoV-2 infection among LTCF residents17; thus, targeted COVID-19 vaccination campaigns, as conducted through the Pharmacy Partnership for Long-Term Care Program, are critical to interrupting virus transmission and decreasing COVID-19–associated morbidity and mortality in LTCFs. Through the Pharmacy Partnership, more than 1.7 million residents and staff members in AL/RC communities received on-site COVID-19 vaccination. First-dose vaccine uptake among both residents and staff increased with subsequent on-site clinics, which could result from doses administered to individuals who were not present at the first clinic (eg, new resident admissions or staff not working during clinic dates) or decreasing vaccine hesitancy over time.

Across 3 states with available resident census data, an estimated median of 78% to 93% of residents were vaccinated at the first on-site clinic in AL communities. These results are consistent with prior analyses indicating that a median of 78% of residents were vaccinated in SNFs during the first month of the program.7 With subsequent clinics, median first-dose uptake among residents in AL communities in these states increased to 88% to 106%. Uptake above 100% likely resulted from new admissions and discharges of residents in these communities; because Pharmacy Partnership data were reported in aggregate at the community level and resident census data were obtained at a single point in time, we could not account or adjust for resident turnover. Other systems to monitor weekly COVID-19 vaccination coverage in long-term care settings, such as the National Healthcare Safety Network (NHSN) LTCF component, can fill this gap following the conclusion of the Pharmacy Partnership program.18 As of June 13, 2021, SNFs are required to report weekly resident and staff COVID-19 vaccination coverage to NHSN.19 Similar vaccination reporting policies for other LTCF settings, including AL/RC communities, could facilitate comprehensive monitoring and evaluation of COVID-19 coverage.

Consistent with our findings, prior analyses of COVID-19 vaccination coverage among the general population by county of residence identified lower vaccination coverage in counties with higher social vulnerability related to socioeconomic status (including income, employment status, and education level) and household composition/disability (including age, single-parent household status, and disability status) but higher vaccination coverage in counties with higher social vulnerability related to racial or ethnic minority status and limited English language fluency.10 Prior analyses examining receipt of COVID-19 vaccine specifically among adults ≥65 years of age also found lower first-dose vaccination coverage associated with social vulnerabilities including poverty, Internet access, and living alone, though no relationship with race or ethnicity.11 Notably, our findings indicated higher uptake associated with social vulnerabilities related to housing type and transportation (including multiunit and mobile home housing, crowding, lack of vehicle availability, and prevalence of institutionalized group quarters), whereas this was not identified among the general population.10 Providing on-site access to vaccination at place of residence or work may help to mitigate access barriers posed by transportation issues, and individuals with these social vulnerabilities may be more likely to seek vaccination through a vaccine delivery program such as the Pharmacy Partnership. With appropriate planning, promotion, and delivery, on-site vaccination programs such as workforce vaccination programs,20 off-site community clinics,21 or mobile clinics22 might similarly increase vaccine uptake across different settings.

These findings are subject to several notable limitations. Firstly, definitions of AL/RC communities vary across jurisdictions, and there may have been misclassification of LTCF types reported to CDC. Resident census data were only available for 3 states and did not include all AL communities within these states; estimated percentage uptake may not be nationally generalizable. We were unable to assess the percentage of staff vaccinated as staffing ratios (number of staff members employed per resident or total bed capacity) vary widely across AL/RC communities.23 In 2014, the national ratio of total nurse and aide staffing hours worked per resident in residential care communities was 2.84 hours per resident per day; state-level estimates ranged from 1.66 to 4.90, indicating wide variability.24 Furthermore, our estimates may underestimate staff member vaccine uptake as we only captured staff vaccinated through the Pharmacy Partnership program and could not account for staff working at multiple communities, intentional staggering of staff vaccination, or staff vaccinated at other locations (eg, at a retail pharmacy). As previously described, we could not account for new resident admissions or discharges at AL/RC communities. Finally, we used county-level estimates of social vulnerability; these factors may vary within large counties, and the characteristics of community locations may not reflect those of residents and staff members admitted from or residing in other localities.

Conclusions and Implications

COVID-19 vaccination of residents and staff members in LTCFs continues to be a public health priority. Though the on-site component of the Pharmacy Partnership for Long-Term Care Program concluded in May 2021, ensuring steady access to vaccine in AL/RC communities and other LTCFs is critical to maintaining high vaccination coverage as new individuals enter the facilities or wish to be vaccinated.6 Additionally, efforts to make vaccine available and accessible to LTCFs and other congregate housing communities with high social vulnerability are critical; delivery strategies such as the on-site clinic model used through the Pharmacy Partnership may help to mitigate access issues related to transportation. Finally, continued, systematic data collection in LTCFs and other high-risk settings is critical to assessing vaccination coverage and impact on COVID-19 disease burden.

Acknowledgments

We thank pharmacy partners from CVS Pharmacy, Managed Health Care Associates, Inc, and Walgreens; residents and staff members in enrolled facilities; state, local, and territorial health departments; Smita Chavan, Sam Cincotta, Nicole Coffin, Rachael Cook, Michelle Hughes, Song Lavalais, Lakshmi Malapati, Adria Mathis, Lauren Moccia, Nadine Shehab, Chelsea Slyker, Nimalie Stone, Kirsten Yates, CDC COVID-19 Response Team; Saahil Madge, Palantir Technologies; Curt Nelson, US Army; and Courtney Bishnoi, David Gifford, Urvi Patel, Lindsay Schwartz, American Health Care Association/National Center for Assisted Living.

Footnotes

The authors declare no conflicts of interest. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

See eg, 45 CFR part 46, 21 CFR part 56; 42 USC §241(d); 5 USC §552a; 44 USC §3501 et seq.

Appendix

Supplementary Table 1.

Facility Characteristics, Clinic Scheduling, and COVID-19 Vaccine First Doses Administered, by State, Among Assisted Living Communities—Pharmacy Partnership for Long-Term Care Program, December 2020–April 2021

Assisted Living (AL) Communities
State/Jurisdiction No. of Participating AL Communities No. of Beds
Clinic 1 Dates
Total First Doses Administered From Clinic 1 to Clinic 3
Median Vaccinated per 100 Beds
Total Across State Median per AL Earliest Latest Rollout Duration, d Residents Staff Residents Staff
AK 360 2228 5 12/30/2020 3/10/2021 70 2154 1701 80 60
AL 182 8167 35 1/7/2021 3/5/2021 57 7616 4927 72 38
AR 37 2642 70 12/29/2020 1/19/2021 21 1877 788 68 25
AZ 648 26,394 10 1/15/2021 3/25/2021 69 21,935 10,465 78 40
CA 1103 70,158 40 1/2/2021 3/4/2021 61 46,299 37,182 70 64
CO 604 25,010 16 12/31/2020 2/2/2021 33 21,532 22,375 75 57
CT 120 12,424 96 12/21/2020 2/5/2021 46 10,054 8447 74 58
DC 7 604 65 1/4/2021 1/16/2021 12 930 521 150 88
DE 30 2166 63 1/5/2021 2/5/2021 31 2158 1412 70 52
FL 1787 81,845 14 12/22/2020 2/12/2021 52 68,851 37,586 82 46
GA 330 24,131 70 1/6/2021 3/4/2021 57 15,824 8805 60 30
HI 17 2057 104 1/2/2021 1/28/2021 26 1952 1866 85 87
IA 260 14,886 48 12/28/2020 2/12/2021 46 10,841 6005 62 33
ID 139 6921 36 12/29/2020 2/15/2021 48 4994 2570 71 31
IL 557 37,400 60 12/29/2020 2/24/2021 57 31,389 21,378 75 44
IN 250 20,737 66 12/29/2020 2/15/2021 48 14,466 5343 65 24
KS 193 8998 36 12/28/2020 2/5/2021 39 8224 4658 76 42
KY 206 11,470 50 12/21/2020 2/3/2021 44 10,122 6090 80 44
LA 116 7472 60 12/29/2020 2/23/2021 56 4566 2509 65 28
MA 259 19,880 78 1/2/2021 2/9/2021 38 17,785 16,597 80 78
MD 769 17,961 8 1/6/2021 3/24/2021 77 17,116 12,709 88 60
ME 90 3910 23 1/4/2021 2/12/2021 39 4500 2170 88 63
MI 707 28,879 20 1/4/2021 3/16/2021 71 23,801 13,349 74 35
MN 711 40,063 44 1/4/2021 2/18/2021 45 32,258 24,790 76 56
MO 278 16,738 52 1/2/2021 2/21/2021 50 13,475 6647 66 31
MS 147 6469 34 1/6/2021 2/7/2021 32 4741 1984 73 27
MT 133 5297 18 12/31/2020 2/12/2021 43 4471 3914 79 45
NC 428 26,729 60 12/28/2020 3/20/2021 82 21,219 10,997 69 33
ND 32 1644 42 12/30/2020 1/28/2021 29 1243 798 78 32
NE 128 7408 46 12/28/2020 2/15/2021 49 5545 3466 71 43
NH 59 3493 56 1/6/2021 2/5/2021 30 3040 2633 79 66
NJ 263 25,862 97 1/2/2021 3/10/2021 67 18,725 15,632 66 48
NM 175 4049 15 12/30/2020 2/11/2021 43 3594 3053 75 67
NV 291 7893 10 12/31/2020 2/25/2021 56 6307 4186 80 60
NY 411 38,560 79 12/30/2020 2/17/2021 49 26,444 20,015 68 41
OH 537 47,625 76 12/18/2020 2/12/2021 56 31,848 20,535 61 34
OK 133 8616 58 1/8/2021 2/4/2021 27 5564 4144 62 35
OR 312 19,276 51 12/21/2020 2/18/2021 59 14,927 10,084 75 48
PA 559 41,641 66 12/29/2020 2/26/2021 59 31,711 23,077 66 45
PR 901 18,535 16 1/4/2021 3/10/2021 65 16,541 12,881 90 67
RI 62 4824 67 12/31/2020 2/18/2021 49 3415 2342 73 46
SC 299 16,184 48 12/28/2020 2/19/2021 53 13,331 6305 74 33
SD 60 2394 29 12/28/2020 1/21/2021 24 2262 520 74 8
TN 278 19,377 60 1/5/2021 3/2/2021 56 12,667 7841 59 34
TX 1250 67,418 42 12/28/2020 3/2/2021 64 55,122 41,833 77 50
UT 147 9282 55 1/2/2021 2/17/2021 46 6622 5301 66 52
VA 377 28,839 72 12/30/2020 2/15/2021 47 24,958 17,185 70 49
VT 49 2092 35 12/30/2020 2/3/2021 35 1780 1425 81 68
WA 366 28,650 64 12/30/2020 2/16/2021 48 25,402 15,396 79 46
WI 1802 31,169 7 1/10/2021 4/6/2021 86 28,627 16,543 81 50
WY 21 1456 61 1/6/2021 1/27/2021 21 967 313 66 22

Supplementary Table 2.

Facility Characteristics, Clinic Scheduling, and COVID-19 Vaccine First Doses Administered, by State, Among Other Residential Care Communities—Pharmacy Partnership for Long-Term Care Program, December 2020–April 2021

Residential Care (RC) Communities
State/Jurisdiction No. of Participating RC Communities No. of Beds
Clinic 1 Dates
Total First Doses Administered From Clinic 1 to Clinic 3
Median Vaccinated per 10 Beds
Total Across State Median per RC Earliest Latest Rollout Duration, d Residents Staff Residents Staff
AK 6 21 4 1/11/2021 2/10/2021 30 15 11 7 2
AL 7 497 62 1/15/2021 2/5/2021 21 343 84 7 1
AR 7 344 60 12/30/2020 1/15/2021 16 229 33 7 1
AZ 113 1312 3 1/16/2021 2/10/2021 25 1213 839 10 7
CA 5318 96,505 6 12/28/2020 4/8/2021 101 66,814 76,509 8 10
CO 29 373 6 1/6/2021 1/28/2021 22 224 466 8 15
CT 191 4442 6 1/4/2021 2/17/2021 44 4460 3226 10 6
DE 34 804 4 1/10/2021 2/8/2021 29 593 424 11 7
FL 312 4927 6 1/11/2021 2/17/2021 37 4849 3390 9 7
GA 113 1437 4 1/11/2021 3/4/2021 52 1335 760 10 7
HI 8 151 19 12/28/2020 1/30/2021 33 157 145 7 9
IA 241 1626 4 1/5/2021 2/13/2021 39 2904 2350 12 8
ID 5 358 50 1/14/2021 1/30/2021 16 210 76 6 1
IL 123 6286 10 12/29/2020 2/24/2021 57 4774 3181 9 5
IN 61 4804 80 1/12/2021 2/18/2021 37 3554 1064 7 1
KS 83 3290 9 12/30/2020 2/9/2021 41 2603 1662 8 6
KY 14 653 49 12/23/2020 2/12/2021 51 718 497 9 6
LA 35 1066 18 1/7/2021 2/6/2021 30 934 598 8 9
MA 1309 11,865 5 1/2/2021 3/15/2021 72 13,275 19,896 10 14
MD 494 5872 5 1/20/2021 3/24/2021 63 12,009 10,135 15 12
ME 124 742 4 12/30/2020 2/22/2021 54 1179 1670 10 20
MI 2484 37,344 6 1/4/2021 4/21/2021 107 27,359 16,157 8 5
MN 412 2815 4 1/9/2021 3/19/2021 69 2577 3154 10 10
MO 213 5437 12 12/29/2020 2/23/2021 56 4061 2579 7 3
MS 22 229 4 1/12/2021 2/5/2021 24 214 83 10 5
NC 303 6913 6 12/28/2020 2/26/2021 60 6284 3621 8 7
ND 9 362 42 12/31/2020 1/14/2021 14 383 176 7 3
NE 1 162 1/17/2021 73 45 5 3
NH 22 802 15 1/6/2021 2/2/2021 27 689 748 9 14
NJ 368 4593 4 1/4/2021 3/6/2021 61 5442 8580 10 13
NM 60 727 4 1/5/2021 1/22/2021 17 1097 1500 10 10
NV 37 719 9 12/30/2020 2/12/2021 44 535 463 9 7
NY 386 7123 8 1/11/2021 2/26/2021 46 7364 7545 10 10
OH 302 3208 3 12/26/2020 2/20/2021 56 2333 1387 10 3
OK 7 502 43 1/16/2021 2/5/2021 20 461 122 6 2
OR 493 3886 5 12/26/2020 2/19/2021 55 3850 3944 9 8
PA 646 7321 3 1/1/2021 2/24/2021 54 7524 10,429 10 15
RI 61 5161 25 1/18/2021 2/14/2021 27 3214 1089 8 3
SC 119 1283 4 12/29/2020 2/19/2021 52 1330 722 10 8
SD 3 56 12 1/8/2021 1/19/2021 11 44 42 6 7
TN 40 1605 6 1/7/2021 2/2/2021 26 1494 459 9 3
TX 169 1587 4 12/28/2020 3/18/2021 80 2477 1447 10 3
UT 72 1786 5 12/28/2020 2/10/2021 44 2071 2599 13 17
VA 337 3256 4 1/10/2021 3/12/2021 61 3423 3838 10 9
VT 71 1473 12 12/23/2020 2/12/2021 51 991 1130 8 6
WA 1045 10,313 6 1/1/2021 3/9/2021 67 8752 10,762 8 7
WI 564 6791 4 1/14/2021 3/16/2021 61 6469 3399 8 4
WY 1 99 1/22/2021 84 110 9 11

References


Articles from Journal of the American Medical Directors Association are provided here courtesy of Elsevier

RESOURCES